ClinicalTrials.gov Search

Search for specific clinical trials that are underway using the keyword search below.

Keywords:

Patient support groups also offer information about clinical trials.

Content Provided By

NINDS Disorders is an index of neurological conditions provided by the National Institute of Neurological Disorders and Stroke. This valuable tool offers detailed descriptions, facts on treatment and prognosis, and patient organization contact information for over 500 identified neurological disorders.

  Print-friendly Version

Kearns-Sayre Syndrome

Kearns-Sayre syndrome (KSS) is a rare neuromuscular disorder with onset usually before the age of 20 years. It is the result of abnormalities in the DNA of mitochondria - small rod-like structures found in every cell of the body that produce the energy that drives cellular functions. The mitochondrial diseases correlate with specific DNA mutations that cause problems with many of the organs and tissues in the body. KSS is characterized by progressive limitation of eye movements until there is complete immobility, accompanied by eyelid droop. It is also associated with abnormal accumulation of pigmented material on the membrane lining the eyes. Additional symptoms may include mild skeletal muscle weakness, heart block (a cardiac conduction defect), short stature, hearing loss, an inability to coordinate voluntary movements (ataxia), impaired cognitive function, and diabetes. Seizures are infrequent. Several endocrine disorders can be associated with KSS.

Treatment

There is currently no effective way to treat mitochondria abnormalities in KSS.  Treatment is generally symptomatic and supportive.  Management of KSS involves multiple specialties depending on the organs involved.  The most essential is a regular and long-term follow-up with cardiologists.  Conduction problems of heart impulse like heart block may be treated with a pacemaker.  Other consultations may include audiology, ophthalmology, endocrinology, neurology, and neuropsychiatry.  Hearing aids may be required.  There is typically no treatment for limitation in eye movement.  Endocrinology abnormalities can be treated with drugs.

Prognosis

KSS is a slowly progressive disorder.  The prognosis for individuals with KSS varies depending on the severity and the number of organs involved.  Early diagnosis and periodic electrocardiogram (ECG) are important since heart block can cause death in 20 percent of patients.  Early pacemaker implantation can be of great benefit and offer a longer life expectancy in many patients.

Research

The NINDS supports research on neuromuscular disorders such as KSS. The goals of this research are to increase understanding of these disorders, and to find ways to prevent, treat, and, ultimately, cure them.  The most promising approach for treatment in the future will be to alter replication or destroy abnormal mitochondria.

View a list of studies currently seeking patients.

View more studies on this condition.

Organizations

Muscular Dystrophy Association

Voluntary health agency that fosters neuromuscular disease research and provides patient care funded almost entirely by individual private contributors. MDA addresses the muscular dystrophies, spinal muscular atrophy, ALS, Charcot-Marie-Tooth disease, myasthenia gravis, Friedreich's ataxia, metabolic diseases of muscle, and inflammatory diseases of muscle, for a total of more than 40 neuromuscular diseases.

3300 East Sunrise Drive
Tucson, AZ 85718-3208
Tel: 520-529-2000 800-572-1717
Fax: 520-529-5300

United Mitochondrial Disease Foundation

Promotes research for cures and treatments of mitochondrial disorders and provides support for affected families. Represents adults and children alike and continues to serve families with a variety of programs.

8085 Saltsburg Road
Suite 201
Pittsburgh, PA 15239
Tel: 412-793-8077 888-317-UMDF (8633)
Fax: 412-793-6477

National Organization for Rare Disorders (NORD)

Federation of voluntary health organizations dedicated to helping people with rare "orphan" diseases and assisting the organizations that serve them. Committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and service.

55 Kenosia Avenue
Danbury, CT 06810
Tel: 203-744-0100 Voice Mail 800-999-NORD (6673)
Fax: 203-798-2291

<< Back